ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $291,000 | – | 14,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
| ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
| AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
| ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
| Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
| Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
| J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |